Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Causes of AA amyloidosis: a systematic review.

Brunger AF, Nienhuis HLA, Bijzet J, Hazenberg BPC.

Amyloid. 2019 Nov 25:1-12. doi: 10.1080/13506129.2019.1693359. [Epub ahead of print]

PMID:
31766892
2.

Coexistence of wild type and hereditary ATTR amyloidosis in one family.

Feenstra JG, Nienhuis HLA, Bijzet J, van der Zwaag PA, van den Berg MP, Hazenberg BPC.

Amyloid. 2019 Nov 13:1-2. doi: 10.1080/13506129.2019.1690444. [Epub ahead of print] No abstract available.

PMID:
31722578
3.

99mTc-aprotinin imaging in cardiac amyloidosis. Make an old tool new again?

Slart RHJA, Glaudemans AWJM, Noordzij W, Nienhuis HLA, Hazenberg BPC.

J Nucl Cardiol. 2019 Oct 10. doi: 10.1007/s12350-019-01917-3. [Epub ahead of print] No abstract available.

PMID:
31602569
4.

Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis.

Connolly MP, Panda S, Patris J, Hazenberg BPC.

Orphanet J Rare Dis. 2019 Sep 18;14(1):220. doi: 10.1186/s13023-019-1199-x.

5.

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging.

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM.

J Card Fail. 2019 Nov;25(11):e1-e39. doi: 10.1016/j.cardfail.2019.08.001. Epub 2019 Aug 29. No abstract available.

PMID:
31473268
6.

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization.

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM.

J Card Fail. 2019 Nov;25(11):854-865. doi: 10.1016/j.cardfail.2019.08.002. Epub 2019 Aug 29.

PMID:
31473267
7.

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM.

J Nucl Cardiol. 2019 Aug 29. doi: 10.1007/s12350-019-01761-5. [Epub ahead of print]

PMID:
31468377
8.

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM.

J Nucl Cardiol. 2019 Aug 29. doi: 10.1007/s12350-019-01760-6. [Epub ahead of print] No abstract available.

PMID:
31468376
9.

Morphological and primary structural consistency of fibrils from different AA patients (common variant).

Liberta F, Rennegarbe M, Rösler R, Bijzet J, Wiese S, Hazenberg BPC, Fändrich M.

Amyloid. 2019 Sep;26(3):164-170. doi: 10.1080/13506129.2019.1628015. Epub 2019 Jun 26.

PMID:
31240945
10.

Time for new imaging and therapeutic approaches in cardiac amyloidosis.

Slart RHJA, Glaudemans AWJM, Noordzij W, Bijzet J, Hazenberg BPC, Nienhuis HLA.

Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1402-1406. doi: 10.1007/s00259-019-04325-4. Epub 2019 Apr 23. No abstract available.

PMID:
31016330
11.

Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial.

Minnema MC, Nasserinejad K, Hazenberg B, Hegenbart U, Vlummens P, Ypma PF, Kröger N, Wu KL, Kersten MJ, Schaafsma MR, Croockewit S, de Waal E, Zweegman S, Tick L, Broijl A, Koene H, Bos G, Sonneveld P, Schönland S.

Haematologica. 2019 Nov;104(11):2274-2282. doi: 10.3324/haematol.2018.213900. Epub 2019 Mar 28.

12.

Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids.

Liberta F, Loerch S, Rennegarbe M, Schierhorn A, Westermark P, Westermark GT, Hazenberg BPC, Grigorieff N, Fändrich M, Schmidt M.

Nat Commun. 2019 Mar 7;10(1):1104. doi: 10.1038/s41467-019-09033-z.

13.

Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis.

van den Berg MP, Mulder BA, Klaassen SHC, Maass AH, van Veldhuisen DJ, van der Meer P, Nienhuis HLA, Hazenberg BPC, Rienstra M.

Eur Heart J. 2019 Apr 21;40(16):1287-1293. doi: 10.1093/eurheartj/ehz057.

14.

Haematological response and overall survival in two consecutive Dutch patient cohorts with AL amyloidosis diagnosed between 2008 and 2016.

Rutten KHG, Raymakers RAP, Hazenberg BPC, Nienhuis HLA, Vellenga E, Minnema MC.

Amyloid. 2018 Dec;25(4):227-233. doi: 10.1080/13506129.2018.1536043. Epub 2018 Dec 4.

PMID:
30513220
15.

Imaging cardiac innervation in hereditary transthyretin (ATTRm) amyloidosis: A marker for neuropathy or cardiomyopathy in case of heart failure?

Jonker DL, Hazenberg BPC, Nienhuis HLA, Slart RHJA, Glaudemans AWJM, Noordzij W.

J Nucl Cardiol. 2018 Oct 29. doi: 10.1007/s12350-018-01477-y. [Epub ahead of print]

PMID:
30374850
16.

Biology/Disease-Driven Initiative on Protein-Aggregation Diseases of the Human Proteome Project: Goals and Progress to Date.

Boersema PJ, Melnik A, Hazenberg BPC, Rezeli M, Marko-Varga G, Kamiie J, Portelius E, Blennow K, Zubarev RA, Polymenidou M, Picotti P.

J Proteome Res. 2018 Dec 7;17(12):4072-4084. doi: 10.1021/acs.jproteome.8b00401. Epub 2018 Sep 28. Review.

PMID:
30137990
17.

Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sjögren's syndrome.

Verstappen GM, Moerman RV, van Nimwegen JF, van Ginkel MS, Bijzet J, Mossel E, Vissink A, Hazenberg BPC, Arends S, Kroese FGM, Bootsma H.

Rheumatology (Oxford). 2018 Oct 1;57(10):1812-1821. doi: 10.1093/rheumatology/key180.

PMID:
29982712
18.

Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.

Treglia G, Glaudemans AWJM, Bertagna F, Hazenberg BPC, Erba PA, Giubbini R, Ceriani L, Prior JO, Giovanella L, Slart RHJA.

Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1945-1955. doi: 10.1007/s00259-018-4013-4. Epub 2018 Apr 23.

PMID:
29687207
19.

Truncation of ADAMTS13 by Plasmin Enhances Its Activity in Plasma.

Clark CC, Mebius MM, de Maat S, Tielens AGM, de Groot PG, Urbanus RT, Fijnheer R, Hazenberg BPC, van Hellemond JJ, Maas C.

Thromb Haemost. 2018 Mar;118(3):471-479. doi: 10.1055/s-0038-1627460. Epub 2018 Mar 13.

PMID:
29534248
20.

Frequency of and Prognostic Significance of Cardiac Involvement at Presentation in Hereditary Transthyretin-Derived Amyloidosis and the Value of N-Terminal Pro-B-Type Natriuretic Peptide.

Klaassen SHC, Tromp J, Nienhuis HLA, van der Meer P, van den Berg MP, Blokzijl H, van Veldhuisen DJ, Hazenberg BPC.

Am J Cardiol. 2018 Jan 1;121(1):107-112. doi: 10.1016/j.amjcard.2017.09.029. Epub 2017 Oct 14.

21.

Imaging cardiac innervation in amyloidosis.

Slart RHJA, Glaudemans AWJM, Hazenberg BPC, Noordzij W.

J Nucl Cardiol. 2019 Feb;26(1):174-187. doi: 10.1007/s12350-017-1059-9. Epub 2017 Sep 8.

22.

Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).

Klaassen SHC, Lemmink HH, Bijzet J, Glaudemans AWJM, Bos R, Plattel W, van den Berg MP, Slart RHJA, Nienhuis HLA, van Veldhuisen DJ, Hazenberg BPC.

Cardiovasc Pathol. 2017 Jul - Aug;29:19-22. doi: 10.1016/j.carpath.2017.04.002. Epub 2017 Apr 18.

23.

Clinical and 123I-SAP scintigraphy findings in three members from a family affected by AGel amyloidosis.

van Rheenen RWJ, Hazenberg BPC, Dierckx RAJO, Glaudemans AWJM.

Amyloid. 2017 Mar;24(sup1):155-156. doi: 10.1080/13506129.2017.1284059. No abstract available.

PMID:
28434313
24.

Diagnostic accuracy of new indirect ELISAs for free light-chain quantification in fat tissue of patients with AL amyloidosis.

Eelsing E, Bijzet J, Hazenberg B.

Amyloid. 2017 Mar;24(sup1):46-47. doi: 10.1080/13506129.2017.1284058. No abstract available.

PMID:
28434310
25.

Kidney Involvement in Systemic Calcitonin Amyloidosis Associated With Medullary Thyroid Carcinoma.

Koopman T, Niedlich-den Herder C, Stegeman CA, Links TP, Bijzet J, Hazenberg BPC, Diepstra A.

Am J Kidney Dis. 2017 Apr;69(4):546-549. doi: 10.1053/j.ajkd.2016.09.027. Epub 2016 Dec 23.

PMID:
28024929
26.

The Prevalence and Management of Systemic Amyloidosis in Western Countries.

Nienhuis HL, Bijzet J, Hazenberg BP.

Kidney Dis (Basel). 2016 Apr;2(1):10-9. doi: 10.1159/000444206. Epub 2016 Feb 25. Review.

27.

Long-term follow-up after surgery in localized laryngeal amyloidosis.

Hazenberg AJ, Hazenberg BP, Dikkers FG.

Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2613-20. doi: 10.1007/s00405-016-4061-y. Epub 2016 May 7.

28.

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN.

Circulation. 2016 Jun 14;133(24):2404-12. doi: 10.1161/CIRCULATIONAHA.116.021612. Epub 2016 Apr 22.

PMID:
27143678
29.

First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy.

Adams D, Suhr OB, Hund E, Obici L, Tournev I, Campistol JM, Slama MS, Hazenberg BP, Coelho T; European Network for TTR-FAP (ATTReuNET).

Curr Opin Neurol. 2016 Feb;29 Suppl 1:S14-26. doi: 10.1097/WCO.0000000000000289. Review.

30.

Obesity-induced chronic inflammation in high fat diet challenged C57BL/6J mice is associated with acceleration of age-dependent renal amyloidosis.

van der Heijden RA, Bijzet J, Meijers WC, Yakala GK, Kleemann R, Nguyen TQ, de Boer RA, Schalkwijk CG, Hazenberg BP, Tietge UJ, Heeringa P.

Sci Rep. 2015 Nov 13;5:16474. doi: 10.1038/srep16474.

31.

Transthyretin-Derived (ATTR) Amyloidotic Cardiomyopathy After Receiving a Domino Liver Allograft.

van den Berg MP, Slart RH, Blokzijl H, Hazenberg BP.

Circulation. 2015 Nov 3;132(18):e216-7. doi: 10.1161/CIRCULATIONAHA.115.016264. No abstract available.

PMID:
26527695
32.

Sensitive and rapid assessment of amyloid by oligothiophene fluorescence in subcutaneous fat tissue.

Sjölander D, Bijzet J, Hazenberg BP, Nilsson KP, Hammarström P.

Amyloid. 2015 Mar;22(1):19-25. doi: 10.3109/13506129.2014.984063. Epub 2014 Nov 19.

PMID:
25847117
33.

Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology.

Hazenberg BP, Croockewit A, van der Holt B, Zweegman S, Bos GM, Delforge M, Raymakers RA, Sonneveld P, Vellenga E, Wijermans PW, von dem Borne PA, van Oers MH, de Weerdt O, Spoelstra FM, Lokhorst HM; Dutch-Belgian Cooperative Trial Group for Hematology Oncology.

Haematologica. 2015 May;100(5):677-82. doi: 10.3324/haematol.2014.119198. Epub 2015 Feb 6.

34.

Nuclear imaging for cardiac amyloidosis.

Noordzij W, Glaudemans AW, Longhi S, Slart RH, Lorenzini M, Hazenberg BP, Rapezzi C.

Heart Fail Rev. 2015 Mar;20(2):145-54. doi: 10.1007/s10741-014-9463-6. Review.

PMID:
25424887
35.

Cardiac diphosphonate uptake.

Noordzij W, Glaudemans AW, Slart RH, Hazenberg BP.

Heart. 2014 Aug;100(15):1192, 1217. doi: 10.1136/heartjnl-2013-305465. Epub 2014 Feb 18. No abstract available.

PMID:
24548918
36.

Additional diagnostic value of SPECT/CT to planar Iodine-123 labeled serum amyloid P component scintigraphy in a patient with pulmonary nodular amyloidosis.

Noordzij W, Glaudemans AW, van Rheenen RW, Dierckx RA, Slart RH, Hazenberg BP.

Amyloid. 2014 Jun;21(2):131-3. doi: 10.3109/13506129.2014.881796. Epub 2014 Jan 30. No abstract available.

PMID:
24479618
37.

Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.

Glaudemans AW, van Rheenen RW, van den Berg MP, Noordzij W, Koole M, Blokzijl H, Dierckx RA, Slart RH, Hazenberg BP.

Amyloid. 2014 Mar;21(1):35-44. doi: 10.3109/13506129.2013.871250. Epub 2014 Jan 23.

PMID:
24455993
38.

Echocardiographic features of an atypical presentation of rapidly progressive cardiac amyloidosis.

Brugts JJ, Houtgraaf J, Hazenberg BP, Kofflard MJ.

World J Cardiol. 2013 May 26;5(5):154-6. doi: 10.4330/wjc.v5.i5.154.

39.

Amyloidosis: a clinical overview.

Hazenberg BP.

Rheum Dis Clin North Am. 2013 May;39(2):323-45. doi: 10.1016/j.rdc.2013.02.012. Epub 2013 Mar 13. Review.

PMID:
23597967
40.

Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis.

Glaudemans AW, Slart RH, Noordzij W, Dierckx RA, Hazenberg BP.

Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1095-101. doi: 10.1007/s00259-013-2375-1. Epub 2013 Mar 9.

PMID:
23474745
41.

Fluorine-18 labeled fluorodeoxyglucose PET useful for therapy monitoring in localized AL amyloidosis?

Noordzij W, Glaudemans AW, Dierckx RA, Slart RH, Boerboom AL, Hazenberg BP.

Amyloid. 2013 Jun;20(2):135-7. doi: 10.3109/13506129.2013.773888. Epub 2013 Feb 28. No abstract available.

PMID:
23448125
42.

Clinical use of differential nuclear medicine modalities in patients with ATTR amyloidosis.

Noordzij W, Glaudemans AW, Slart RH, Dierckx RA, Hazenberg BP.

Amyloid. 2012 Dec;19(4):208-11. doi: 10.3109/13506129.2012.717993. Epub 2012 Aug 22.

PMID:
22913327
43.

(123)I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis.

Noordzij W, Glaudemans AW, van Rheenen RW, Hazenberg BP, Tio RA, Dierckx RA, Slart RH.

Eur J Nucl Med Mol Imaging. 2012 Oct;39(10):1609-17. Epub 2012 Jul 18.

44.

Ageing: a risk factor for amyloid A amyloidosis in rheumatoid arthritis.

Hazenberg BP.

Amyloid. 2012 Mar;19(1):56-7. doi: 10.3109/13506129.2011.649322. Epub 2012 Feb 8. No abstract available.

PMID:
22313333
45.

Measurable regression of systemic light chain (AL) amyloid in fat tissue after a response of amyloidogenic free light chain in serum.

van Gameren II, Bijzet J, Bos R, Limburg PC, Vellenga E, Hazenberg BP.

Amyloid. 2011 Jun;18 Suppl 1:94-5. doi: 10.3109/13506129.2011.574354034. No abstract available. Erratum in: Amyloid. 2011 Jun;18 Suppl 1:95.

PMID:
21838446
46.

Diagnostic performance of transthyretin measurement in fat tissue of patients with ATTR amyloidosis.

Hazenberg BP, van Schijndel B, Bijzet J, Limburg PC, Bos R, Haagsma EB.

Amyloid. 2011 Jun;18 Suppl 1:79. doi: 10.3109/13506129.2011.574354028. No abstract available. Erratum in: Amyloid. 2011 Jun;18 Suppl 1:79.

PMID:
21838440
47.

Diagnostic performance of measuring free light chains in fat tissue of patients with AL amyloidosis.

Bijzet J, van Gameren II, Limburg PC, Bos R, Vellenga E, Hazenberg BP.

Amyloid. 2011 Jun;18 Suppl 1:71-2. doi: 10.3109/13506129.2011.574354025. No abstract available. Erratum in: Amyloid. 2011 Jun;18 Suppl 1:72.

PMID:
21838437
48.

Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.

Kappelle PJ, Bijzet J, Hazenberg BP, Dullaart RP.

Arch Med Res. 2011 Apr;42(3):219-25. doi: 10.1016/j.arcmed.2011.05.002.

PMID:
21722818
49.

Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema.

Bos R, de Waal EG, Kuiper H, Hazenberg BP, Vellenga E.

Rheumatology (Oxford). 2011 Oct;50(10):1925-6. doi: 10.1093/rheumatology/ker209. Epub 2011 Jun 29. No abstract available.

PMID:
21719421
50.

Amyloid load in fat tissue reflects disease severity and predicts survival in amyloidosis.

van Gameren II, Hazenberg BP, Bijzet J, Haagsma EB, Vellenga E, Posthumus MD, Jager PL, van Rijswijk MH.

Arthritis Care Res (Hoboken). 2010 Mar;62(3):296-301. doi: 10.1002/acr.20101.

Supplemental Content

Loading ...
Support Center